These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28093142)

  • 21. Bending the Curve of Advanced Urothelial Carcinoma.
    Geynisman DM; Plimack ER
    J Oncol Pract; 2017 May; 13(5):319-320. PubMed ID: 28489979
    [No Abstract]   [Full Text] [Related]  

  • 22. Genomic Characterization of Upper Tract Urothelial Carcinoma.
    Sfakianos JP; Cha EK; Iyer G; Scott SN; Zabor EC; Shah RH; Ren Q; Bagrodia A; Kim PH; Hakimi AA; Ostrovnaya I; Ramirez R; Hanrahan AJ; Desai NB; Sun A; Pinciroli P; Rosenberg JE; Dalbagni G; Schultz N; Bajorin DF; Reuter VE; Berger MF; Bochner BH; Al-Ahmadie HA; Solit DB; Coleman JA
    Eur Urol; 2015 Dec; 68(6):970-7. PubMed ID: 26278805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ASO Author Reflections: Dialysis and Recurrence in Urothelial Cancer.
    Lin MY; Hwang SJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):978-979. PubMed ID: 30374918
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma.
    Junker K; Ohlmann CH
    Eur Urol; 2017 Aug; 72(2):316-317. PubMed ID: 28341322
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma.
    Black PC
    Eur Urol; 2017 Oct; 72(4):653-654. PubMed ID: 28583313
    [No Abstract]   [Full Text] [Related]  

  • 26. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Mouse and Human Urothelial Cancer Organoids: A Tool for Bladder Cancer Research.
    Atala A
    J Urol; 2019 Oct; 202(4):664. PubMed ID: 31287759
    [No Abstract]   [Full Text] [Related]  

  • 28. Of Chemoimmunotherapy Sequences and Delayed Disease-modifying Activity in Advanced Urothelial Carcinoma: Vetus Fit Novum.
    Necchi A; Anichini A; Sonpavde G
    Eur Urol; 2018 Feb; 73(2):153-155. PubMed ID: 28967552
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: J. Alberto Nakauma-González, Maud Rijnders, Job van Riet, et al. Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma. Eur Urol 2022;81:331-6: Novel Insights into Evidence of Metastatic Urothelial Carcinoma Transcriptomic Subtype.
    Song Y; Qin C; Xu T
    Eur Urol; 2022 Sep; 82(3):e76-e77. PubMed ID: 35715367
    [No Abstract]   [Full Text] [Related]  

  • 30. Invasive micropapillary urothelial carcinoma of the bladder.
    Lopez-Beltran A; Montironi R; Blanca A; Cheng L
    Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does solitary- and organ-confined metastasectomy really improve survival in advanced urologic malignancies?
    Tonyali S; Yazici S
    Int Urol Nephrol; 2016 May; 48(5):671-80. PubMed ID: 26843415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: Molecular Classification of Urothelial Carcinoma: Global mRNA Classification Versus Tumour-cell Phenotype Classification.
    Peeker R
    Eur Urol; 2018 May; 73(5):809-810. PubMed ID: 29273405
    [No Abstract]   [Full Text] [Related]  

  • 33. Genetic analysis of hMLH1 in transitional cell carcinoma of the urinary tract: promoter methylation or mutation.
    Furihata M; Takeuchi T; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
    J Urol; 2001 May; 165(5):1760-4. PubMed ID: 11342971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.
    Ali SM; Miller VA; Ross JS; Pal SK
    Eur Urol; 2015 Jun; 67(6):1195-1196. PubMed ID: 25630452
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Richard J. Sylvester, Willem Oosterlinck, Sten Holmang, et al. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.05.050.
    Williams SB; Lamm DL; Kamat AM
    Eur Urol; 2015 Dec; 68(6):e127. PubMed ID: 26318707
    [No Abstract]   [Full Text] [Related]  

  • 36. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-urothelial tumors of the urinary tract].
    Mikuz G
    Verh Dtsch Ges Pathol; 1993; 77():180-98. PubMed ID: 7511278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer: uPAR expression indicates worse prognosis of urothelial carcinoma.
    Sidaway P
    Nat Rev Urol; 2015 Mar; 12(3):120. PubMed ID: 25644167
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemoimmunotherapy in Metastatic Urothelial Carcinoma.
    Geynisman DM; Abbosh PH; Plimack ER; Zibelman M
    Eur Urol; 2018 May; 73(5):760-762. PubMed ID: 29331216
    [No Abstract]   [Full Text] [Related]  

  • 40. Transitional cell and uncommon urothelial carcinoma of renal pelvis/ureter and bladder: low incidence of human papilloma virus.
    Wang JS; Tseng HH; Lin SL; Hsieh SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):151-7. PubMed ID: 9198289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.